Genentech, Inc., Intermune, Inc. v. Sandoz Inc., Lek Pharmaceuticals, D.d.

N OTE: This order is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
GENENTECH, INC., INTERMUNE, INC.,
Plaintiffs-Appellants
v.
SANDOZ INC., LEK PHARMACEUTICALS, D.D.,
Defendants-Appellees
______________________
2022-1595
______________________
Appeal from the United States District Court for the
District of Delaware in No. 1:19-cv-00078-RGA, Judge
Richard G. Andrews.
-------------------------------------------------
GENENTECH, INC., INTERMUNE, INC.,
Plaintiffs-Appellees
v.
SANDOZ INC., LEK PHARMACEUTICALS, D.D.,
Defendants-Appellants
______________________
2022-1714
______________________
Case: 22-1595 Document: 24 Page: 1 Filed: 06/16/2022

-- 1 of 2 --

GENENTECH , INC. v. SANDOZ INC. 2
Appeal from the United States District Court for the
District of Delaware in No. 1:19-cv-00078-RGA, Judge
Richard G. Andrews.
______________________
ON MOTION
______________________
O R D E R
Upon consideration of the parties’ joint motion to vol-
untarily dismiss Appeal No. 2022-1714,
I T I S O RDERED T HAT :
(1) The motion is granted. Appeal No. 2022-1714 is
dismissed. The revised official caption for the remaining
appeal, Appeal No. 2022-1595, is reflected above.
(2) Each side shall bear its own costs in Appeal No.
2022-1714.
(3) The Clerk of Court shall transmit a copy of this or-
der to the merits panel assigned to Appeal No. 2022-1595.
(4) Genentech, Inc. and InterMune, Inc.’s reply brief in
Appeal No. 2022-1595 is due no later than July 5, 2022.
June 16, 2022
Date
F OR THE COURT
/s/ Peter R. Marksteiner
Peter R. Marksteiner
Clerk of Court
ISSUED AS A MANDATE (as to 2022-1714 only):
June 16, 2022
Case: 22-1595 Document: 24 Page: 2 Filed: 06/16/2022

-- 2 of 2 --